In the current study, we concentrated on the signaling pathways where PARM1 was involved, and we showed that PARM1 could induce PASMC proliferation via an AKT/FOXO3A/PCNA-dependent signaling pathway in PAH. The gene discussed is AKT1; the disease is pulmonary arterial hypertension.